| Product Code: ETC9522971 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname sterile injectable contract manufacturing import shipments in 2024 were primarily sourced from the United States, Netherlands, Brazil, Peru, and the United Kingdom. Despite a high concentration with a high Herfindahl-Hirschman Index (HHI), the industry experienced a significant decline with a CAGR of -22.78% from 2020 to 2024. The growth rate in 2024 saw a sharp decrease of -60.7% compared to the previous year, indicating challenges and shifts in the market dynamics impacting the import of sterile injectables in Suriname.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Sterile Injectable Contract Manufacturing Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume, 2022 & 2032F |
3.3 Suriname Sterile Injectable Contract Manufacturing Market - Industry Life Cycle |
3.4 Suriname Sterile Injectable Contract Manufacturing Market - Porter's Five Forces |
3.5 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume Share, By Molecule Type, 2022 & 2032F |
3.6 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume Share, By Therapeutic Application, 2022 & 2032F |
3.7 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.8 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume Share, By End-use Outlook, 2022 & 2032F |
4 Suriname Sterile Injectable Contract Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Suriname Sterile Injectable Contract Manufacturing Market Trends |
6 Suriname Sterile Injectable Contract Manufacturing Market, By Types |
6.1 Suriname Sterile Injectable Contract Manufacturing Market, By Molecule Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Molecule Type, 2022 - 2032F |
6.1.3 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Small Molecule, 2022 - 2032F |
6.1.4 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Large Molecule, 2022 - 2032F |
6.2 Suriname Sterile Injectable Contract Manufacturing Market, By Therapeutic Application |
6.2.1 Overview and Analysis |
6.2.2 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Cancer, 2022 - 2032F |
6.2.3 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Diabetes, 2022 - 2032F |
6.2.4 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Cardiovascular Diseases, 2022 - 2032F |
6.2.5 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Central Nervous System Diseases, 2022 - 2032F |
6.2.6 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Infectious Disorders, 2022 - 2032F |
6.2.7 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Musculoskeletal, 2022 - 2032F |
6.3 Suriname Sterile Injectable Contract Manufacturing Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Subcutaneous (SC), 2022 - 2032F |
6.3.3 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Intravenous (IV), 2022 - 2032F |
6.3.4 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Intramuscular (IM), 2022 - 2032F |
6.3.5 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Others, 2022 - 2032F |
6.4 Suriname Sterile Injectable Contract Manufacturing Market, By End-use Outlook |
6.4.1 Overview and Analysis |
6.4.2 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Pharmaceutical Companies, 2022 - 2032F |
6.4.3 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Biopharmaceutical Companies, 2022 - 2032F |
6.4.4 Suriname Sterile Injectable Contract Manufacturing Market Revenues & Volume, By Others, 2022 - 2032F |
7 Suriname Sterile Injectable Contract Manufacturing Market Import-Export Trade Statistics |
7.1 Suriname Sterile Injectable Contract Manufacturing Market Export to Major Countries |
7.2 Suriname Sterile Injectable Contract Manufacturing Market Imports from Major Countries |
8 Suriname Sterile Injectable Contract Manufacturing Market Key Performance Indicators |
9 Suriname Sterile Injectable Contract Manufacturing Market - Opportunity Assessment |
9.1 Suriname Sterile Injectable Contract Manufacturing Market Opportunity Assessment, By Molecule Type, 2022 & 2032F |
9.2 Suriname Sterile Injectable Contract Manufacturing Market Opportunity Assessment, By Therapeutic Application, 2022 & 2032F |
9.3 Suriname Sterile Injectable Contract Manufacturing Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.4 Suriname Sterile Injectable Contract Manufacturing Market Opportunity Assessment, By End-use Outlook, 2022 & 2032F |
10 Suriname Sterile Injectable Contract Manufacturing Market - Competitive Landscape |
10.1 Suriname Sterile Injectable Contract Manufacturing Market Revenue Share, By Companies, 2025 |
10.2 Suriname Sterile Injectable Contract Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here